Status:
COMPLETED
Evaluating the Effect of a Supplement on Symptoms of Hormonal Imbalance.
Lead Sponsor:
Perelel Inc.
Collaborating Sponsors:
Citruslabs
Conditions:
Women's Health
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This is a virtual single-group trial lasting 12 weeks to evaluate the effects of Perelel Health's hormonal balance support on symptoms of hormonal imbalance and overall menstrual health.
Eligibility Criteria
Inclusion
- Self-reported symptoms of hormonal imbalance (e.g., mood swings, irregular menstrual cycles)
- Generally healthy without uncontrolled chronic diseases
- Willing to avoid new hormonal balance treatments during the study
- Consistent use of current hormonal balance treatments for at least 3 months prior to the study
Exclusion
- Chronic conditions preventing adherence to the protocol Diabetes
- Planned hormonal balance-related procedures during the study
- Started any new medications or supplements that target hormonal balance in the past 3 months
- Anyone with diabetes
- Severe allergies requiring EpiPen
- Pregnant, breastfeeding, or trying to conceive
- Recent surgeries or planned surgeries during the study
- Unwilling to follow the study protocol
Key Trial Info
Start Date :
February 19 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 10 2024
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT06535698
Start Date
February 19 2024
End Date
June 10 2024
Last Update
August 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Citruslabs
Santa Monica, California, United States, 90404